The Latest Headlines at Ticker Report
What BTGO (BTGO) Said on Its Q3 Earnings Call
BitGo Holdings, BTGO (NYSE:BTGO), reported a 50.9% year-over-year decline in third-quarter revenue as weaker digital asset trading and a shift toward lower-margin stablecoin transactions weighed on results. The company posted net... More of this article »
Contrasting Alexander’s (ALX) & Its Rivals
Alexander’s (NYSE:ALX – Get Free Report) is one of 111 public companies in the “Diversified REITs” industry, but how does it compare to its rivals? We will compare Alexander’s to related businesses based... More of this article »
Radiant Logistics Q1 Earnings Call Highlights
Radiant Logistics (NYSEAMERICAN:RLGT) reported higher revenue and earnings for its fiscal first quarter, as strength in U.S. freight services and disaster-relief air shipments helped lift adjusted EBITDA. Revenue for the quarter ended... More of this article »
Celldex Therapeutics Targets 2027 Filing for Barzolvolimab After Phase 3 Results
Celldex Therapeutics (NASDAQ:CLDX) plans to submit a biologics license application for barzolvolimab in 2027, using full 52-week data from its Phase 3 studies in chronic spontaneous urticaria, executives said at Guggenheim’s 3rd... More of this article »
5,590 Shares of ExxonMobil Corporation $XOM Bought by Pavion Blue Capital LLC
Pavion Blue Capital LLC bought a new position in shares of ExxonMobil Corporation (NYSE:XOM – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.... More of this article »
ExxonMobil Corporation $XOM Stock Position Lifted by Ritholtz Wealth Management
Ritholtz Wealth Management raised its position in shares of ExxonMobil Corporation (NYSE:XOM – Free Report) by 10.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange... More of this article »
Equities Analysts Set Expectations for ZNTL FY2026 Earnings
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – HC Wainwright boosted their FY2026 EPS estimates for shares of Zentalis Pharmaceuticals in a report issued on Tuesday, November 10th. HC Wainwright analyst A.... More of this article »
Comparing Griffon (NYSE:GFF) & FGI Industries (NASDAQ:FGI)
FGI Industries (NASDAQ:FGI – Get Free Report) and Griffon (NYSE:GFF – Get Free Report) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their risk,... More of this article »
KB Financial Group (NYSE:KB) versus First Bank (NASDAQ:FRBA) Critical Analysis
First Bank (NASDAQ:FRBA – Get Free Report) and KB Financial Group (NYSE:KB – Get Free Report) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their... More of this article »
Critical Comparison: American Tower (NYSE:AMT) & Lamar Advertising (NASDAQ:LAMR)
Lamar Advertising (NASDAQ:LAMR – Get Free Report) and American Tower (NYSE:AMT – Get Free Report) are both large-cap real estate companies, but which is the better business? We will compare the two companies based on the... More of this article »
InMode (NASDAQ:INMD) Stock Price Target Lowered at Robert W. Baird
InMode (NASDAQ:INMD – Get Free Report) had its price target cut by equities researchers at Robert W. Baird from $17.00 to $15.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “neutral”... More of this article »
Azenta (NASDAQ:AZTA) Stock Price Expected to Rise, Needham & Company LLC Analyst Says
Azenta (NASDAQ:AZTA – Get Free Report) had its target price increased by Needham & Company LLC from $37.00 to $57.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on... More of this article »
NRx Pharmaceuticals (NASDAQ:NRXP) Stock Price Expected to Rise, BTIG Research Analyst Says
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) had its target price hoisted by equities researchers at BTIG Research from $10.00 to $12.00 in a research report issued to clients and investors on Wednesday, Benzinga reports.... More of this article »